The following are selected presentations from the 12th Congress of the European Academy of Neurology, held June 27-30, 2026 in Geneva, Switzerland
Ocrelizumab discontinuation
Role of fluid biomarkers in practice
Cyclophosphamide vs. siponimod in SPMS
Relapse during pregnancy in MOGAD, NMOSD
GLP-1 signalling in NMOSD
Read More
The following are selected presentations from the 12th Congress of the European Academy of Neurology, held June 27-30, 2026 in Geneva, Switzerland
Are annual MRIs necessary?
Effect of HE DMTs on PIRA
Impact of ofatumumab on brain atrophy
Frexalimab long-term results
Increasing prevalence of NMOSD in Finland
Read More
Click here to watch Dr. Jiwon Oh discuss the case and your responses to the quick poll.
Ellen is a 48-year-old elementary teacher with a history of migraine dating back to her twenties. She is perimenopausal with hot flashes and fatigue, and a recent increase in migraine frequency to 5-6 headaches per month. Her family physician diagnosed depression two years ago and started Ellen on a trial of sertraline. Read More
Click here to watch Dr. Virginia Devonshire discuss the case and your responses to the quick poll.
Michael P. is a 55-year-old male diagnosed with relapsing MS five years ago. He presented with a spinal cord relapse that resulted in residual sensory and mild bladder dysfunction in his lower limbs and EDSS 2.5. His MRI had a thoracic lesion and more than 10 brain lesions meeting McDonald 2017 criteria. He was started on teriflunomide 14 mg/day but reported poor tolerability. Read More